Area of research
Epidemiology · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Herpes simplex virus and Virology, with related work in Heparanase, Immune system, Virus. Notable publications include 'Herpes Simplex Virus Cell Entry Mechanisms: An Update', 'Dysregulation of Cell Signaling by SARS-CoV-2', and 'Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections'.
A deep dive into radiation keratopathy; Going beyond the current frontiers
Ocular graft-versus-host disease (oGVHD): From A to Z
Wound-Healing Effects of Mesenchymal Stromal Cell Secretome in the Cornea and the Role of Exosomes
Applications of mesenchymal stem cells in ocular surface diseases: sources and routes of delivery
From the diagnosis of infectious keratitis to discriminating fungal subtypes; a deep learning-based study
Intrastromal versus subconjunctival injection of mesenchymal stem/stromal cells for promoting corneal repair
Concise Review: Bioengineering of Limbal Stem Cell Niche
Cellular senescence and ophthalmic diseases: narrative review
Artificial Intelligence and Infectious Keratitis: Where Are We Now?
Cellular senescence implication in mustard keratopathy
Therapeutic Potential of Mesenchymal Stem Cell-Secreted Factors on Delay in Corneal Wound Healing by Nitrogen Mustard
Topical phenylbutyrate antagonizes NF-κB signaling and resolves corneal inflammation
Herpes Simplex Virus Cell Entry Mechanisms: An Update
Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer
Pathobiology and treatment of viral keratitis
Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis
mTORC2 confers neuroprotection and potentiates immunity during virus infection
Intrinsic Antiviral Activity of Optineurin Prevents Hyperproliferation of a Primary Herpes Simplex Virus Type 2 Infection
Dysregulation of Cell Signaling by SARS-CoV-2
Heparanase, cell signaling, and viral infections
Vaccines and Therapies in Development for SARS-CoV-2 Infections
Standalone or combinatorial phenylbutyrate therapy shows excellent antiviral activity and mimics CREB3 silencing
Pharmaceutically Acceptable Carboxylic Acid-Terminated Polymers Show Activity and Selectivity against HSV-1 and HSV-2 and Synergy with Antiviral Drugs
<i>In Vitro</i> and <i>In Vivo</i> Activity, Tolerability, and Mechanism of Action of BX795 as an Antiviral against Herpes Simplex Virus 2 Genital Infection
Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections
Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress
Prior inhibition of AKT phosphorylation by BX795 can define a safer strategy to prevent herpes simplex virus-1 infection of the eye